ALK Genomic Tumor Aberrations
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB18879 | Alintegimod | 1 / 2 | Recruiting | 1 |
| DB06186 | Ipilimumab | 1 / 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 / 2 | Recruiting | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB18879 | Alintegimod | 1 / 2 | Recruiting | 1 |
| DB06186 | Ipilimumab | 1 / 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 / 2 | Recruiting | 1 |